Phase I/II trial of oncolytic reovirus (Reolysin) in combination with carboplatin/paclitaxel in patients (pts) with advanced solid cancers

被引：0
|
作者：
Karapanagiotou, E. [1 ,2 ,3 ,4 ]
Pandha, H. S. [1 ,2 ,3 ,4 ]
Hall, G. [1 ,2 ,3 ,4 ]
Chester, J. [1 ,2 ,3 ,4 ]
Melcher, A. [1 ,2 ,3 ,4 ]
Coffey, M. [1 ,2 ,3 ,4 ]
de Bono, J. [1 ,2 ,3 ,4 ]
Gore, M. E. [1 ,2 ,3 ,4 ]
Nutting, C. M. [1 ,2 ,3 ,4 ]
Harrington, K. J. [1 ,2 ,3 ,4 ]
机构：
[1] Royal Marsden Hosp, NHS Fdn Trust, London SW3 6JJ, England
[2] Univ Surrey, Guildford GU2 5XH, Surrey, England
[3] Leeds Inst Mol Med, Leeds, W Yorkshire, England
[4] Oncolyt Biotech Inc, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14519
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I Trial of Oncolytic Reovirus (Reolysin) in Combination With Carboplatin/Paclitaxel in Patients With Advanced Solid Cancers
    Karapanagiotou, Eleni
    Pandha, Hardev
    Hall, Geoff
    Chester, John
    Melcher, Alan
    De Bono, Johann
    Gore, Martin
    Nutting, Christopher
    Harrington, Kevin
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 952 - 952
  • [2] Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies
    Karapanagiotou, Eleni M.
    Roulstone, Victoria
    Twigger, Katie
    Ball, Mercel
    Tanay, MaryAnne
    Nutting, Chris
    Newbold, Kate
    Gore, Martin E.
    Larkin, James
    Syrigos, Konstantinos N.
    Coffey, Matt
    Thompson, Brad
    Mettinger, Karl
    Vile, Richard G.
    Pandha, Hardev S.
    Hall, Geoff D.
    Melcher, Alan A.
    Chester, John
    Harrington, Kevin J.
    CLINICAL CANCER RESEARCH, 2012, 18 (07) : 2080 - 2089
  • [3] A phase I/II study of oncolytic reovirus plus carboplatin/paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck(SCCHN)
    Karapanagiotou, E. M.
    Chester, J. D.
    Pandha, H. S.
    Gill, G. M.
    Coffey, M. C.
    Mettinger, K.
    Harrington, K. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma
    Devalingam Mahalingam
    Christos Fountzilas
    Jennifer Moseley
    Nicole Noronha
    Hue Tran
    Romit Chakrabarty
    Giovanni Selvaggi
    Matthew Coffey
    Brad Thompson
    John Sarantopoulos
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 697 - 703
  • [5] Phase I trial of bartezomib in combination with paclitaxel in advanced solid tumor patients (pts).
    Shapiro, CL
    Ramaswamy, B
    Young, D
    Lamb, T
    Lucas, D
    Shaaf, L
    Sahenk, Z
    Collamore, M
    Byrd, J
    Wright, J
    Grever, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 217S - 217S
  • [6] Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy
    Flaherty, KT
    Stevenson, JP
    Hahn, SM
    Redlinger, M
    O'Dwyer, PJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (03) : 217 - 222
  • [7] Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy
    Keith T. Flaherty
    James P. Stevenson
    Stephen M. Hahn
    Maryann Redlinger
    Peter J. O'Dwyer
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 217 - 222
  • [8] Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
    M Harries
    A O'Donnell
    M Scurr
    S Reade
    C Cole
    I Judson
    A Greystoke
    C Twelves
    S Kaye
    British Journal of Cancer, 2004, 91 : 1651 - 1655
  • [9] Phase I trial of intratumoral administration of reovirus type 3 (Reolysin) in combination with radiation in patients with advanced malignancies
    Vidal, L.
    Twigger, K.
    White, C. L.
    Ahmed, M.
    Pandha, H. S.
    Nutting, C. M.
    De Bono, J. S.
    Kaye, S. B.
    Melcher, A.
    Harrington, K. J.
    CANCER RESEARCH, 2006, 66 (08)
  • [10] A phase I/II study of oncolytic reovirus plus chemotherapy (carboplatin/paclitaxel) in patients with advanced solid tumors (with emphasis on patients with squamous cell carcinoma of the head and neck (SCCHN)
    Harrington, Kevin J.
    Karapanagiotou, Eleni M.
    Hardev, Pandha
    Nutting, Christopher M.
    Gore, Martin
    Karl, Mettinger
    Geoff, Hall
    Melcher, Alan
    Mercel, Ball
    Coffey, Matt
    Thompson, Brad
    Chester, John
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
12345